DrugPatentWatch Database Preview
Drugs in Development Information for PBT-1033
Email this page to a colleague
See Plans and PricingWhat is the development status for investigational drug PBT-1033?
PBT-1033 is an investigational drug.
There have been 5 clinical trials for PBT-1033.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2008.
The most common disease conditions in clinical trials are Esophageal Neoplasms, Carcinoma, Non-Small-Cell Lung, and Acne Vulgaris. The leading clinical trial sponsors are Mayo Clinic, M.D. Anderson Cancer Center, and GlaxoSmithKline.
Summary for PBT-1033
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2008-02-01) |
| Vendors | 9 |
Recent Clinical Trials for PBT-1033
| Title | Sponsor | Phase |
|---|---|---|
| Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | National Cancer Institute (NCI) | Phase 3 |
| Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | NRG Oncology | Phase 3 |
| Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy | xjpfW | N/A |
Clinical Trial Summary for PBT-1033
Top disease conditions for PBT-1033
Top clinical trial sponsors for PBT-1033
US Patents for PBT-1033
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
